Contraceptive Technology Update – January 1, 2007
January 1, 2007
View Archives Issues
-
Research eyes expanded use for intrauterine systems in women
Consider the many treatment options when presented with the following cases: the perimenopausal woman with prolonged menstrual bleeding due to uterine leiomyomas; the young woman with significant pain from spreading endometriosis; and the mother with menorrhagia. Which options will you choose? -
Providers in swing with Implanon training
Your patient is a 29-year-old mother of three active young children. She has had limited success with using birth control pills and says that the daily dosing schedule is a challenge. She shakes her head "no" to the contraceptive patch and vaginal ring, and she doesn't want to limit her options with the choice of tubal sterilization. -
Shipment of dual-label EC now reaching stores
Access to emergency contraception (EC) has been expanded. Shipments of the new dual-label version of Plan B, the levonorgestrel-only EC drug, are now hitting pharmacy market shelves. -
Research emerges on continuous regimen OC
When using contraception to delay or stop menstrual periods, return to fertility is important to patients. Results of a national survey indicate 58% of women worry that menstrual suppression will affect their ability to have children. -
Review the options for premenstrual syndrome
When is "that time of month" a problem for some women? When symptoms such as depression, wide mood swings, breast tenderness, or muscle pain enter into the picture, a diagnosis of premenstrual syndrome (PMS) may be in order. However, when symptoms are more severe, clinicians may consider a diagnosis of premenstrual dysphoric disorder (PMDD). -
Update practice on osteoporosis prevention
The next patient in your exam room is in her mid-40s. She notes that her last monthly period was 11 months ago. She continues to use condoms for pregnancy prevention. She has a thin body and a small bone frame, and she smokes 15-20 cigarettes a day. Her medical history indicates a family history of osteoporosis. What is your next move? -
STD Quarterly: Family planning providers get in gear to offer new HPV vaccine to young women
Access to Gardasil (Merck & Co., Whitehouse Station, NJ) continues to expand as the shot has been added to the federal Vaccines for Children (VFC) program for young women ages 9 to 18. The program is administered at the national level by the Centers for Disease Control and Prevention (CDC) through its National Immunization Program. -
STD Quarterly: Reinfection is common after STD treatment
You have just written a prescription for an adolescent female to treat a chlamydial infection. When you close her file, what are the chances it will reappear in your inbox in the next month or two?